<!DOCTYPE html>
<html>

<title>Muckteshwari Gupta</title>
<style>

h1,h2 {
    color: red;
    text-align: left;
} /* This is
a multi-line
comment */
</style>

<body>
	<h1>MUCKTESHWARI GUPTA</h1>

	<p>3477 Lily Way Apt# 511, San Jose, CA 95134 | Phone: (512)920-4646 | muckti@gmail.com</p>

	<h2>SUMMARY</h2>
	    <ul>
		    <li>Over 7 years of experience in Global Generic Pharmaceutical Industry, with a strong background in project management and technology transfer.
			<li>Proactive, performance-driven professional with successful track record of managing and delivering projects.</li>
			<li>Hand on understanding of Pharmaceutical functions including Development, Manufacturing, Quality Assurance and Regulatory affairs; able to communicate with people of different backgrounds, to resolve problems for smooth flow of project.</li>
			<li>Expertise in Solid dosage formulation (tablet & capsule) including Immediate and modified release, successfully completed tech transfer of more than 50 ANDA.</li> 
			<li>Well organized, detail-oriented and flexible professional, who enjoys learning new skills and adapts to changing priorities.</li>
		</ul> 


	<h2>ACHIEVEMENTS AND AWARDS</h2>

		<ul>
			<li>Appreciated at Cipla-India for managing site transfer project that has reduced operation cost by $1M.</li>
			<li>Spot & excellence award at Novartis Sandoz-India for successful tech transfer of FTF & process improvement products.</li>
			<li>Best Performance award at Dr. Reddys labs-India for increasing revenue by complex scale up & site transfer of 5 products.</li>
			<li>Appreciated and awarded at Ipca-India for reducing spheronization cycle time of pellet products by 70%.</li>
			<li>Subject matter expert during USFDA, MHRA, TGA, MCC, WHO & customer audits on tech transfer.</li>
		</ul> 

	<h2>PROFESSIONAL EXPERIENCE</h2>
		
		<p>Therapeutic focus areas include: Immunology, Cardiology/ vascular disease, Infections and Infectious Diseases, Gastroenterology, nephrology.</p>

		<h3><p><a href="http://www.cipla.com/">Cipla Labs Ltd</a>, Mumbai- India					    (Sept 2013-May 2014)</p></h3>
		<p><i>An Indian multinational pharmaceutical and biotechnology company. Cipla is world's largest manufacturer of antiretroviral drug with presence in over 150 countries.</i></p>

		<h3>Project Manager</h3>
		<ul>
			<li>Successfully managed site transfer project of 10 solid oral dosages for commercialization in US, EU and ROW market.</li>
			<li>Led planning and execution of 5 Multihaler product development projects with 3 different packing configuration from development phase to commercialization. This includes responsibilities for facilities, equipment, supply chain, CROs, CMOs, vendor services, resource management, operating procedures, policies and standards.</li>
			<li>Experience in project management software & quality tool applications including WBS, Gantt Chart, Pareto Analysis, Resource allocation, ROI, Key deliverables, Cost analysis and Cost effectiveness. </li>
			<li>Prepared project charter that contains purpose, success criteria, requirements, description, high level risk, summary milestone schedule & budget, project approval requirements, identification of stakeholders & team members, assigned responsibility and authority level.</li>
			<li>Managed and maintained up-to-date MS Project Timelines inclusive of all critical milestones, key interdependencies within triple constraints of delivering on time, within budget (Cost Modelling) and scope objectives.</li>
			<li>Conducted periodic reviews with stakeholders and cross functional team (CMC team, Regulatory, manufacturing, Supply chain, Quality assurance etc) and update report, minutes, tracking sheet to ensure that phase/gate transition criteria are met in the most efficient manner.</li>
			<li>Negotiated, resolved conflicts and drove consensus among team/functional members to accomplish project goals.</li>
			<li>Developed risk mitigation plan after conducting detailed risk assessment by analyzing documents, statistics, reports and market trends.</li>
		</ul>  

		<h3><p><a href="http://www.sandoz.com/">Sandoz a Novartis Company</a>, Mumbai- India					    (Sept 2011-Aug 2013)</p></h3>

		<p>Sandoz, the generic pharmaceuticals division of Novartis with a history of 120 years, is a worldwide leader in generics with presence in more than 160 countries. Sandoz is also the pioneer and global leader in Bio-similar.</p>

		<h3>Executive – Manufacturing Science & Technology</h3>
		<ul>
			<li>Executed various batches including product scale-up, optimization, submission, validation and commercial launch for ANDA and MAA submissions using RTR, QbD, process capability index and Multivariate SPC.</li>
			<li>As a part of site to site transfer and R&D to site transfer, successfully transferred 20 ANDA products (Tablet and Capsules) from Germany, Slovenia and within India.</li>
			<li>Used statistical process techniques (QbD, process capability index, Multivariate SPC) to execute process improvement and cost reduction projects that have significantly reduced the product cost, improved product quality and increased yield by 10%.</li>
			<li>Optimized machine parameters, product characteristics and tooling to resolve compression problem associated with multilayer tablet and tablet in tablet formulation.</li>
			<li>Prepared and executed CAPA using root cause & Impact analysis to investigate OOS/OOE/Deviation.</li>
			<li>Executed process improvement, variation filing, cost reduction and troubleshooting batches according to SUPAC and European Variation Guidelines.</li>
			<li>Prepared and Reviewed SOPs, product annual reports, manufacturing and packaging instructions.</li>
			<li>Authorized process validation protocols and reports to determine the process range.</li>
			<li>Initiated change requests for equipment modification and process improvement projects.</li>
		</ul>  


		<h3><p><a href="http://www.drreddys.com/">Dr. Reddy’s Labs Ltd</a>, Hyderabad- India					    (April 2010- Aug 2011)</p></h3>

		<p>Global pharmaceutical and Biotechnology company, operates in three segments: Global Generics, Pharmaceutical Services, Active Ingredients and Proprietary Products. It markets more than 76 drugs in the United States.</p>

		<h3>Senior Executive – Technology Transfer Group</h3>
		<ul>
			<li>Developed manufacturing and packaging process of oral solid dosage formulations for more than 20 ANDAs, 10 MAA with 6 different packing configurations for regulatory submissions.</li>
			<li>Successfully executed RTR site transfer activity for 5 modified release formulation that involves critical process parameters like drug layering & coating using wruster coater.</li>
			<li>Supported deviation investigations and perform risk assessments to resume production, proposed practical CAPA’s using Failure Mode Effect Analysis to eliminate reoccurrence.</li>
			<li>Assisted in regulatory filings and prepared 14 manufacturing packages as per the Module 3 requirements.</li>
			<li>Applied DOE principles on various process improvement projects, that has significantly improved particle size distribution and uniformity.</li>
			<li>Performed DOEs to determine starting process parameters and acceptable operating ranges, led process validation protocols and coordinated activities such as sample collection, data analysis and preparation of validation reports.</li>
			<li>Addressed and provided supporting data for the questions posed in the FDA deficiency letter.</li>
		</ul>  

		<h3><p><a href="http://www.ipca.com/">Ipca Labs Ltd</a>, Pithampur- India					     (July 2007- Apr 2010)</p></h3>

		<p>Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs, presence in over 110 countries. The company is a leader in India for anti-malarial with a fast expanding presence in the international market.</p>

		<h3>Jr. Officer – Technology Transfer Group</h3>
		<ul>
			<li>Executed various batches for oral solid ANDA formulation including Optimization, Exhibit and Process Validation.</li>
			<li>Hands on experience with encapsulation, pellet manufacturing and wruster coating process, reduced spheronization cycle time of pellet by 70% and resolve the dissolution variation in extended release formulation.</li>
			<li>Thorough knowledge of granulation, sizing, drying, compression and coating process, identified and resolved low drug assay problem in dry compaction formulation.</li>
			<li>Played a key role in preparing Site Master File, Validation Master Plan and SOPs (equipment operation, cleaning and general system).</li>
			<li>Assisted with equipment qualification (IQ, OQ and PQ) to achieve and maintain compliance.</li>

		</ul>  

	<h2>EDUCATION & PROFESSIONAL TRAINING</h2>
		<ul>
			<li>Patent Diploma, WIPO Academy: 2010</li>
			<li>BS - Pharmacy, Rajiv Gandhi Technical University, SCOPE Indore, India: July 2003- June 2007</li>
		</ul> 
	<h2>HIGHLIGHTS OF PROFESSIONAL DEVELOPMENT</h2>
		<ul>
			<li>Fundamentals of Project Management” and “Implementation of Project Management techniques”. </li>
			<li>cGMP” and Process Validation.</li>
			<li>Innovation in Granulation, Pelletization and Coating Technologies. </li>
		</ul> 
	<h2>COMPUTER SKILLS </h2>

		<ul>
			<li>Microsoft -Excel, Outlook, PowerPoint, Word, Project.</li>
			<li>Windows NetMeeting, Cisco WebEx, Microsoft LiveMeeting, SharePoint.</li>
			<li>SAP, Project management and production Software, TrackWise, Lotus notes.</li>
		</ul> 
	</body>
	</html>


